DE1770135A1 - Verfahren zur Herstellung von 2,4-Benzdiazepinen - Google Patents

Verfahren zur Herstellung von 2,4-Benzdiazepinen

Info

Publication number
DE1770135A1
DE1770135A1 DE19681770135 DE1770135A DE1770135A1 DE 1770135 A1 DE1770135 A1 DE 1770135A1 DE 19681770135 DE19681770135 DE 19681770135 DE 1770135 A DE1770135 A DE 1770135A DE 1770135 A1 DE1770135 A1 DE 1770135A1
Authority
DE
Germany
Prior art keywords
group
lower alkyl
formula
radical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681770135
Other languages
German (de)
English (en)
Inventor
Stevens George De
Rodriguez Hermann Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE1770135A1 publication Critical patent/DE1770135A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19681770135 1967-04-13 1968-04-05 Verfahren zur Herstellung von 2,4-Benzdiazepinen Pending DE1770135A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63049767A 1967-04-13 1967-04-13
US69442167A 1967-12-29 1967-12-29

Publications (1)

Publication Number Publication Date
DE1770135A1 true DE1770135A1 (de) 1971-09-23

Family

ID=27091165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681770135 Pending DE1770135A1 (de) 1967-04-13 1968-04-05 Verfahren zur Herstellung von 2,4-Benzdiazepinen

Country Status (5)

Country Link
BE (1) BE713698A (en:Method)
CH (3) CH527828A (en:Method)
DE (1) DE1770135A1 (en:Method)
FR (2) FR1588463A (en:Method)
GB (1) GB1183135A (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475527A3 (en) * 1990-09-10 1992-06-17 Sterling Drug Inc. Aryl-fused and hetaryl-fused-2, 4-diazepine and 2, 4-diazocine antiarrhythmic agents

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
CA2104060A1 (en) * 1992-11-10 1994-05-11 Robert Ed Johnson Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
GB9425701D0 (en) * 1994-12-20 1995-02-22 Wellcome Found Enzyme inhibitors
MY148233A (en) * 2003-12-15 2013-03-29 Merck Sharp & Dohme Heterocyclic aspartyl protease inhibitors
PE20070531A1 (es) 2005-10-27 2007-07-13 Schering Corp Compuestos heterociclicos como inhibidores de aspartil proteasas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475527A3 (en) * 1990-09-10 1992-06-17 Sterling Drug Inc. Aryl-fused and hetaryl-fused-2, 4-diazepine and 2, 4-diazocine antiarrhythmic agents

Also Published As

Publication number Publication date
GB1183135A (en) 1970-03-04
CH527828A (de) 1972-09-15
BE713698A (en:Method) 1968-10-14
FR7495M (en:Method) 1969-12-08
CH523264A (de) 1972-05-31
CH511863A (de) 1971-08-31
FR1588463A (en:Method) 1970-04-17

Similar Documents

Publication Publication Date Title
DE69209969T2 (de) Wasserlösliche Camptothecinderivate
DE2915318C2 (en:Method)
DE3008056C2 (en:Method)
DE2928485A1 (de) Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
DE2100242A1 (de) Gegen Trypanosomiasis wirksame, substituierte Nitroimidazole
EP0063381A1 (de) Neue Pyrazolo(3,4-d)pyrimidine, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE69024778T2 (de) 2-Aminopyrimidin-4-carboxamid-Derivate, deren Herstellung und deren therapeutische Anwendung
DE2433397A1 (de) Piperazinylchinoxaline
DE3125471C2 (de) Piperazinderivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2617205B2 (de) 2-(l-Piperazinyl)-pyrazine, deren Herstellung und diese enthaltende anorektische Mittel
DE1770135A1 (de) Verfahren zur Herstellung von 2,4-Benzdiazepinen
DE2064874A1 (de) Verfahren zur Herstellung von neuen 5-Nitrofurylderivaten. Ausscheidung aus: 2052719
EP1581506A1 (de) Verwendung von 2-amino-2h-chinazolin-derivaten zur herstellung von therapeutischen mitteln
DE2055889C2 (de) 2-Alkyl-s-triazolo [1,5-a] [1,4] benzodiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0456133A1 (de) Hydrazone
EP0575425A1 (de) VERWENDUNG VON OXAZOLO- 2,3-a]ISOINDOL- UND IMIDAZO 2,1-a]ISOINDOL-DERIVATEN ALS ANTIVIRALE ARZNEIMITTEL SOWIE NEUE OXAZOLO 2,3-a]ISOINDOL-DERIVATEN.
DE2427207A1 (de) Verfahren zur herstellung von kondensierten pyrrolmercapto-verbindungen
DE1670389A1 (de) Neue quaternaere 5-Ammonium-methyl-4-amino-pyrimidinsalzverbindungen
DD154487A5 (de) Verfahren zur herstellung von 1-benzoxepin-5(2h)-on-derivaten
US3162634A (en) Z-methyl-j-
DE69023964T2 (de) Verwendung von Isoxazolin-3-one-Derivaten als Antidepressiva.
DE2544382A1 (de) Tricyclische dicarboximide
NZ204072A (en) Pharmaceutical compositions which contain theophylline as active ingredient
DE602005001434T2 (de) Arylpiperazinderivate als selektive Liganden für den Dopamin D3 Rezeptor
US3928437A (en) Phenoxy-phenyl, phenylthiophenyl, phenylsulfonylphenyl and phenylaminophenyl diaminothioureas